Clinical trials
Completed Phase 2 Uterine Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Montefiore Medical Center | 3 |
| M.D. Anderson Cancer Center | 2 |
| Amgen | 1 |
| Dana-Farber Cancer Institute | 1 |
| Gradalis, Inc. | 1 |
| Jeanne Drisko, MD, CNS, FACN | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Leap Therapeutics, Inc. | 1 |
| Mary Crowley Medical Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 27 |
| Endometrial Neoplasms | 10 |
| Ovarian Neoplasms | 8 |
| Uterine Cervical Neoplasms | 6 |
| Genital Neoplasms, Female | 4 |
| Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Carcinoma | 2 |
| Carcinosarcoma | 2 |
| Leiomyoma | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.